Atlas Trials

Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults

Clinical trial NCT04179929 · RECRUITING

Trial details

NCT number
NCT04179929
Sponsor
PETHEMA Foundation
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia
Start date
2019-11-25
Primary completion
2026-11-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.